Macrolides - PDFSEARCH.IO - Document Search Engine

Macrolides
Results: 352

#	Item
111	June 23, 2008 Submit an sNDA for the immunosuppressant Prograf® for Ulcerative Colitis in Japan Japan, June 23, [removed]Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) to Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-17 23:51:41 Immunosuppressants Macrolides Tacrolimus Astellas Pharma Colitis Autoimmune diseases Ulcerative colitis Intestine Atopic dermatitis Health Medicine Gastroenterology
112	September 19, 2007 Astellas Submitted a Response to the FDA Action Letter for FK506 Modified Release Formulation for Kidney Transplantation Japan, September 19, [removed]Astellas Pharma Inc. (headquarters: Tokyo, presiden Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 20:50:47 Macrolides Tacrolimus Transplantation medicine Astellas Pharma Immunosuppressive drug Kidney transplantation Transplant rejection Organ transplantation Heart transplantation Medicine Organ transplants Immunosuppressants
113	Brigham and Woman’s Hospital/ Harvard Medical School Boston, USA Department of Translational Medicine (Director: Thomas P. Stossel, MD) and Add to Reading List Source URL: www.marshallplan.at Language: English - Date: 2014-09-30 20:59:05 Proteins Genodermatoses Tuberous sclerosis Immunosuppressants Macrolides Sirolimus Tuberous sclerosis protein Mammalian target of rapamycin TSC1 Biology Medicine Health
114	Torisel® (temsirolimus) for Kidney Cancer Indication: Torisel is a medication used to treat advanced kidney cancer in adults Dosage: 25 mg Route of administration: Intravenous infusion Schedule: Once a week What is the Add to Reading List Source URL: dev66.geckodesigns.com Language: English - Date: 2014-10-30 16:14:47 Temsirolimus Kidney cancer Medicine Oncology Macrolides
115	November 20, 2014 Regeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis TARRYTOWN, N.Y. and PARIS, Nov. 20, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, I Add to Reading List Source URL: files.shareholder.com Language: English Medicine Immunosuppressants Macrolides Atopic dermatitis Regeneron Eczema Pharmacology Dermatitis Atopy Health Type 1 hypersensitivity Immune system
116	Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Pediatric Postmarketing Pharmacovigilance and Dru Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical industry Immunosuppressants Macrolides Clinical pharmacology Everolimus Pharmacovigilance Food and Drug Administration Sirolimus Adverse effect Medicine Pharmaceutical sciences Pharmacology
117	NIH Public Access Author Manuscript J Natl Cancer Inst. Author manuscript; available in PMC 2009 July 1. NIH-PA Author Manuscript Add to Reading List Source URL: www.bhdsyndrome.org Language: English - Date: 2011-03-17 20:08:21 Birt–Hogg–Dubé syndrome Kidney cancer Sirolimus Mammalian target of rapamycin Folliculin AKT Renal cell carcinoma Kidney Cell culture Biology Immunosuppressants Macrolides
118	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ELIDEL® safely and effectively. See full prescribing information for ELIDEL®. ELIDEL® (pimecrolimus) Cream, 1% fo Add to Reading List Source URL: elidel-us.com Language: English - Date: 2014-06-19 10:56:32 Chemistry Health Pimecrolimus Medicine Eczema Atopic dermatitis Ascomycin Atopy Dermatitis Immunosuppressants Type 1 hypersensitivity Macrolides
119	Microsoft Word - Tacrolimus NDA Acceptance Release FINAL.docx Add to Reading List Source URL: www.astellas.com Language: English - Date: 2012-12-04 18:27:38 Macrolides Tacrolimus Astellas Pharma Transplantation medicine Kidney transplantation Liver transplantation Transplant rejection Medicine Organ transplants Immunosuppressants
120	Award ID: RP130276 Project Title: The mTOR-dependent nuclear transport in cancer Award Mechanism: Individual Investigator Add to Reading List Source URL: www.cprit.state.tx.us Language: English - Date: 2014-11-20 01:49:18 Ribozymes Macrolides Mammalian target of rapamycin Signal transduction Ribosome Nucleolus Cell growth Sirolimus Ribosomal RNA Biology Cell biology Protein biosynthesis

UPDATE